Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-01-20 5:17 pm Sale | 2022-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND | BlackRock Inc. BLK | 2,789,479 16.500% | -1,607,242 (-36.56%) | Filing History |
| 2022-02-14 10:39 am Sale | 2021-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND | MACQUARIE GROUP LTD | 1,001,825 3.740% | -462,760 (-31.60%) | Filing History |
| 2022-02-11 6:20 pm Sale | 2021-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND | CARDINAL CAPITAL MANAGEMENT LLC | 260,661 1.000% | -1,483,828 (-85.06%) | Filing History |
| 2022-02-11 1:24 pm Sale | 2022-02-11 | 13G | Ligand Pharmaceuticals Incorporated LGND | WASATCH ADVISORS LP | 312,901 1.200% | -1,561,001 (-83.30%) | Filing History |
| 2022-02-11 1:10 pm Sale | 2021-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND | STATE STREET CORP STT | 1,422,427 5.310% | -445,693 (-23.86%) | Filing History |
| 2022-02-10 4:35 pm Sale | 2021-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND | JANUS HENDERSON GROUP PLC JHG | 2,310,059 8.600% | -274,568 (-10.62%) | Filing History |
| 2022-02-10 08:22 am Sale | 2021-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND | VANGUARD GROUP INC | 2,751,926 10.270% | -8,906 (-0.32%) | Filing History |
| 2022-02-09 6:54 pm Purchase | 2021-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND | WILLIAM BLAIR INVESTMENT MANAGEMENT LLC | 2,244,747 8.400% | 193,631 (+9.44%) | Filing History |
| 2022-01-27 11:00 am Unchanged | 2021-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND | BlackRock Inc. BLK | 4,396,721 16.400% | 0 (Unchanged) | Filing History |
| 2022-01-25 3:03 pm Purchase | 2021-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND | BlackRock Inc. BLK | 4,396,721 16.400% | 1,245,230 (+39.51%) | Filing History |
| 2021-10-12 09:29 am Purchase | 2021-09-30 | 13G | Ligand Pharmaceuticals Incorporated LGND | VANGUARD GROUP INC | 2,760,832 10.330% | 422,176 (+18.05%) | Filing History |
| 2021-05-07 3:55 pm Sale | 2021-04-30 | 13G | Ligand Pharmaceuticals Incorporated LGND | WILLIAM BLAIR INVESTMENT MANAGEMENT LLC | 2,051,115 7.700% | -1,220,680 (-37.31%) | Filing History |
| 2021-02-16 5:30 pm Purchase | 2020-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND | CARDINAL CAPITAL MANAGEMENT LLC | 1,744,489 6.800% | 269,738 (+18.29%) | Filing History |
| 2021-02-16 09:34 am Sale | 2020-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND | STATE STREET CORP STT | 1,868,120 7.250% | -141,580 (-7.04%) | Filing History |
| 2021-02-12 10:15 am Purchase | 2020-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND | MACQUARIE GROUP LTD | 1,464,586 5.680% | 1,464,586 (New Position) | Filing History |
| 2021-02-11 4:42 pm Sale | 2020-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND | JANUS HENDERSON GROUP PLC JHG | 2,584,628 10.000% | -376,450 (-12.71%) | Filing History |
| 2021-02-11 2:54 pm Purchase | 2020-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND | WILLIAM BLAIR INVESTMENT MANAGEMENT LLC | 3,271,795 12.700% | 233,511 (+7.69%) | Filing History |
| 2021-02-10 6:16 pm Sale | 2020-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND | RENAISSANCE TECHNOLOGIES LLC | 0 0.000% | -1,636,966 (Position Closed) | Filing History |
| 2021-02-10 11:14 am Sale | 2020-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND | VANGUARD GROUP INC | 2,338,657 9.070% | -178,074 (-7.08%) | Filing History |
| 2021-02-09 3:06 pm Purchase | 2021-02-09 | 13G | Ligand Pharmaceuticals Incorporated LGND | WASATCH ADVISORS LP | 1,873,902 7.300% | 1,873,902 (New Position) | Filing History |